Nutrien (NYSE:NTR – Get Free Report) had its price objective boosted by stock analysts at Oppenheimer from $76.00 to $78.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price objective indicates a potential upside of 3.90% from the stock’s current price.
Several other research firms have also issued reports on NTR. Weiss Ratings reissued a “hold (c)” rating on shares of Nutrien in a research report on Monday, December 29th. Barclays boosted their price objective on Nutrien from $64.00 to $70.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 18th. Bank of America increased their target price on Nutrien from $64.00 to $71.00 and gave the company a “neutral” rating in a research note on Friday, February 20th. Jefferies Financial Group raised their target price on Nutrien from $60.00 to $74.00 and gave the company a “hold” rating in a report on Monday. Finally, BMO Capital Markets upped their price target on Nutrien from $75.00 to $85.00 and gave the stock an “outperform” rating in a report on Friday, February 20th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Nutrien presently has a consensus rating of “Hold” and an average price target of $72.24.
View Our Latest Research Report on Nutrien
Nutrien Price Performance
Nutrien (NYSE:NTR – Get Free Report) last released its quarterly earnings data on Wednesday, February 18th. The company reported $0.83 earnings per share for the quarter, missing the consensus estimate of $0.87 by ($0.04). The firm had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The business’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.31 earnings per share. As a group, research analysts predict that Nutrien will post 3.72 EPS for the current year.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in the stock. Montag A & Associates Inc. raised its stake in shares of Nutrien by 310.7% in the 4th quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after purchasing an additional 320 shares in the last quarter. Root Financial Partners LLC acquired a new stake in Nutrien during the third quarter valued at approximately $37,000. Sfam LLC acquired a new position in shares of Nutrien in the 4th quarter worth approximately $37,000. Huntington National Bank grew its position in shares of Nutrien by 72.6% in the 2nd quarter. Huntington National Bank now owns 656 shares of the company’s stock worth $38,000 after acquiring an additional 276 shares in the last quarter. Finally, Eastern Bank raised its position in shares of Nutrien by 133.0% during the 4th quarter. Eastern Bank now owns 699 shares of the company’s stock valued at $43,000 after acquiring an additional 399 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.
Nutrien Company Profile
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Featured Stories
- Five stocks we like better than Nutrien
- 3 Signs You May Want to Switch Financial Advisors
- Unlocked: Elon Musk’s Next Big IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
- The Man Who Predicted the iPhone Says Buy These 3 Companies
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
